Park's Materials Flashcards
Physiologic effects of androgens
changes during puberty in males
hair growth
oily skin (acne)
muscle growth
increased LDL, decreased HDL
aggressiveness
physiologic effects of estrogens
changes during puberty in female
endometrium growth
increased blood coagulability
maintenance of bone density
decreased LDL, increased HDL
mood
physiologic effects of progestin
maturation of endometrium
maintenance of pregnancy
physiologic effects of glucocorticoids
increase in blood glucose levels
anti-inflammation
immunosuppression
physiologic effects of mineralocorticoids
increase in blood Na+ levels
increase in blood volume
oral steroids
17-methyl or 17-ethynyl groups
hepatotoxicity
IM steroids
large alkyl groups at 17 (enanthate, valerate, cypionate)
preparations in oil
depot injection
anti-androgen subclasses
5a-reductase inhibitors
androgen receptor antagonists
5a-reductase inhibitors
Finasteride, Dutasteride
block the conversion of testosterone into 5a-dihydrotesterone
Androgen receptor antagonists
Cyproterone Acetate, Spironolactone, Flutamide, Enzalutamide
prevents the binding/activation of androgen receptors
Estrogen drug classes
conjugated estrogens (Premarin)
Agonists
SERMs (partial agonists)
Anti-estrogens (SERD, aromatase inhibitors)
Estrogen agonists
Diethylstilbestrol, Chlorotrianisene
increases estrogen levels in the addition of an OH group
SERMs
partial agonists that have some estrogenic and some androgenic activity
blocks helix 12 properties
Tamoxifen, Toremifene, Ospemifene, Raloxifene, Clomiphene
Anti-Estrogens
Fluvestrant (SERD)
Aromatase Inhibitors –> Anastrazole, Letrozole, Exemestane (prevents testosterone conversion into 17b-estradiol and androstenedione into estrone)
systemic glucocorticoids
hydrocortisone
cortisone
prednisone
prednisolone
methylprednisolone
triamcinolone
dexamethasone
betamethasone
binds to cortisol receptor and activates to treat adrenal insufficiency
inhaled glucocorticoids
triamcinolone acetonide
beclomethasone dipropionate
budesonide
flunisolide
mometasone furoate
fluticasone propionate
ciclesonide
binds to GRE to change the rate of transcription
treats asthma/COPD
topical glucocorticoids
triamcinolone acetonide
fluocinonide
betamethasone valerate
clobestasol propionate
halobetasol propionate
halcinonide
binds to NFkB to repress transcription of cytokine genes
anti-inflammatory agents
systemic mineralocorticoids
fludrocortisone
used in replacement therapy to treat addison’s disease with low levels of aldosterone
cushing’s disease
hyperadrenalism
primary, pituitary, ectopic
symptoms –> weight gain, thin arms and legs, moon face, increase protein catabolism, osteoporosis, opportunistic infections
caused by long-term use of systemic glucocorticoids
different between cushing’s disease types
adrenal –> decreased CRH/ACTH, increased cortisol
pituitary –> decreased CRH, increased ACTH/cortisol
ectopic –> decreased CRH/ACTH, increased cortisol/ectopic ACTH
adrenal insufficiency
hypoadrenalism
primary (addison’s disease), secondary
symptoms –> extreme weakness, anorexia, anemia, low BP (in primary only), mental depression
caused by cessation of long-term systemic glucocorticoid therapy
COX
enzymes that synthesize eicosanoids
1 - housekeeping
2 - inflammatory
PGE
vasodilation
PGF
vasoconstriction
PGI
inhibition (suppression) of platelet aggregation
TXA
promotion of platelet aggregation
NSAID drug classes
salicylates
arylacetic acids
arylpropionic acids
non-carboxylate
cox-2 selective (celecoxib)
NSAID SE
GI upset
renal
hypersensitivity
suppression of blood coagulation (aspirin)
reye’s syndrome (aspirin)
NSAIDs for short-term use
indomethacin
ketorolac